Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
about
Triglycerides in the human kidney cortex: relationship with body sizeA case of lipoprotein glomerulopathy with thrombotic microangiopathy due to malignant hypertensionRenal lipid metabolism and lipotoxicity.Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathySystemic and renal lipids in kidney disease development and progression.Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E.Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.Proteomics Approach Identifies Factors Associated With the Response to Low-Density Lipoprotein Apheresis Therapy in Patients With Steroid-Resistant Nephrotic Syndrome.A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate.A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I.The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
P2860
Q28542644-72830E78-871B-4B15-BB47-A3FE0BCEE305Q33406143-57FC30D6-E932-4476-BC64-BAFADAB05F4BQ34825296-B52C157C-CD32-483B-AD49-CBF1374B005FQ36462050-0DF5E393-154D-4641-A4BB-D37AD4D638C1Q37148885-20621C88-3B07-4B20-8085-A2309A38F479Q37449083-9471FE5E-36B8-4153-AB57-681A1D65FEABQ38154771-B2DD6028-C523-4848-B169-150E693D8C9EQ38176982-8F1AD093-A189-4930-8A49-41570ECE0249Q38191186-1309FFEA-EC23-4E49-BDA6-6655BD424842Q40104072-DD2C3C85-6556-4A74-A487-DD803C87C359Q42365684-A5A2ADDC-B229-43EB-9E9E-34FFEEF8C35AQ45172544-E7623465-B304-4163-AC06-BA4DF54D6C65Q48194471-12C72109-7D26-4801-976F-A7B743E7742EQ49339404-A625B1EF-097C-43EB-ADF1-FF800BDC9914
P2860
Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Lipoprotein glomerulopathy: a ...... h enhanced glomerular binding.
@ast
Lipoprotein glomerulopathy: a ...... h enhanced glomerular binding.
@en
type
label
Lipoprotein glomerulopathy: a ...... h enhanced glomerular binding.
@ast
Lipoprotein glomerulopathy: a ...... h enhanced glomerular binding.
@en
prefLabel
Lipoprotein glomerulopathy: a ...... h enhanced glomerular binding.
@ast
Lipoprotein glomerulopathy: a ...... h enhanced glomerular binding.
@en
P2093
P1476
Lipoprotein glomerulopathy: a ...... h enhanced glomerular binding.
@en
P2093
Ashok K Singh
George Dunea
Jose A L Arruda
Melvin M Schwartz
Ted Mazzone
P304
P356
10.1053/J.AJKD.2005.12.031
P577
2006-03-01T00:00:00Z